Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: erythromycin base attending: chief complaint: several months of massively increase r arm, r face and r chest wall edema. major surgical or invasive procedure: 1. recanalization and angioplasty of right brachiocephalic vein. 2. thoracentesis 3. stenting 4. insertion of chest tube 5. vats pleurodesis history of present illness: as in primary summary past medical history: as in primary summary social history: tobacco + professor family history: n/a physical exam: intake exam: tm=100, tc=98.3 120/60 hr=103 rr=22 o2sat=94%@ra nad heent: peerla, mildly edematous r face/neck chest: suggestion of distant bs on r heart: tachy, irregular rythm, no mmr abd: soft, nt/nd ext: r av fistula w/ bruit/thrill. marked edema, bruising of r arm. radial pulse palp b pertinent results: 11:00am pleural wbc-167* rbc-* polys-21* lymphs-13* monos-0 macro-66* 04:53pm pleural wbc-197* rbc-* polys-12* lymphs-22* monos-41* nrbc-1* meso-5* macro-19* 11:00am pleural totprot-3.6 glucose-118 ld(ldh)-127 amylase-70 albumin-2.2 04:53pm pleural totprot-2.8 glucose-120 ld(ldh)-75 amylase-83 albumin-1.9 02:30pm other body fluid wbc-25* rbc-5800* polys-62* lymphs-13* monos-7* mesothe-6* macro-12* 02:30pm other body fluid totprot-3.5 glucose-96 ld(ldh)-1493 amylase-75 05:32am blood wbc-9.1 rbc-3.00* hgb-9.2* hct-29.6* mcv-99* mch-30.6 mchc-31.1 rdw-15.9* plt ct-363 05:32am blood pt-19.3* ptt-76.8* inr(pt)-2.5 05:32am blood plt ct-363 08:20pm blood pt-13.1 ptt-28.5 inr(pt)-1.1 08:20pm blood plt ct-263 05:32am blood glucose-103 urean-23* creat-4.5*# na-142 k-3.6 cl-103 hco3-27 angap-16 08:20pm blood glucose-88 urean-56* creat-8.3*# na-138 k-5.0 cl-93* hco3-29 angap-21* 05:32am blood calcium-9.1 phos-3.4 mg-2.0 08:20pm blood calcium-10.6* phos-4.8* mg-2.9* all blood cultures neg for growth brief hospital course: the prior discharge summary leaves off at s/p stenting of the r brachiocephalic vein. following the thoracentesis, the r pleural effusion was monitored by serial cxr, and was seen to reaccumulate within 5 days, during which time, her 02 demand increased. pulmonary was consulted and was unable to help determine a medical etiology for the effusion. at this time, she was transfered to the vicu setting, and thoracentesis via ultrasound was repeated on ; it productive of less fluid then the original tap but without complication. neither tap was suggestive of a frank bleed (see lab results). she was then intubated, brought to the icu. a chest ct on suggested a patent stent with a large, freely-layering right pleural effusion as well as associated compressive atelectasis without evidence of large mass. since the effusion was felt to be refractory to thoracentesis, thorsasic surgery was consulted to place and manage a chest tube (). tube drainage was not felt to provide therapuetic improvement in her lung function, and on , thorasic surgery took her for a vats pleurodesis. since that time, she has continued to improve both in her clinical demands for supplementary oxygen and in her serial cxrs. on , her cxr was significant for a marked reduction in the right pleural effusion, and she was maintaining an o2 sat of 92% on room air, at rest. medications on admission: same as below, with the exception of diltiazem 90 qid discharge medications: 1. levothyroxine sodium 25 mcg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. pyridoxine hcl 100 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 4. cyanocobalamin 500 mcg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 5. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po qd (once a day) as needed. disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 6. aspirin, buffered 325 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 7. warfarin sodium 1 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 8. diltiazem hcl 90 mg tablet sig: one (1) tablet po qid (4 times a day). disp:*120 tablet(s)* refills:*2* 9. diphenhydramine hcl 25 mg capsule sig: one (1) capsule po once (once) for 1 doses. disp:*30 capsule(s)* refills:*0* 10. sevelamer hcl 800 mg tablet sig: four (4) tablet po q breakfast and supper (). 11. sevelamer hcl 800 mg tablet sig: three (3) tablet po q lunch (). 12. sevelamer hcl 800 mg tablet sig: one (1) tablet po before snack prn (). 13. albuterol sulfate 0.083 % solution sig: inhalation q6h (every 6 hours) as needed. 14. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po qd (once a day). 15. nephrovite 1 tab po qd discharge disposition: extended care facility: eagle rehabilitation center - discharge diagnosis: primary: right brachiocephalic vein occlusion right-sided pleural effusion secondary: right-sided pneumothorax chronic renal failure requiring hemodialysis atrial fibrillation gout l5 spondylothisthesis discharge condition: fair-good discharge instructions: if you experience any chest pain, shortness of breath, or fevers/chills, please seek immediate medical attention. please call go to the er if you experience worsening shortness of breath. followup instructions: provider: , d. appointment should be in days please call dr. (thoracic surgery) office at ( and set up follow up appointment for . please follow up inr levels in clinic or primary care physician as before. please follow up lab results with clinic. md procedure: insertion of intercostal catheter for drainage continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube hemodialysis angioplasty of other non-coronary vessel(s) thoracentesis transpleural thoracoscopy insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) injection into thoracic cavity transfusion of packed cells diagnoses: anemia, unspecified unspecified pleural effusion atrial fibrillation iatrogenic pneumothorax 

Answer: The patient is high likely exposed to